Market Overview:
The global acetazolamide market is expected to grow at a CAGR of 5.5% from 2018 to 2030. The growth in the market can be attributed to the increasing prevalence of glaucoma and other ophthalmic disorders, rising awareness about the benefits of acetazolamide, and technological advancements in the field of ophthalmology. Based on type, the global acetazolamide market is segmented into tablets, capsules, and injections. The tablets segment is expected to account for the largest share of the global acetazolamide market in 2018. This can be attributed to their easy availability and low cost as compared to other forms such as capsules and injections. Based on application, the global acetazolamide market is segmented into hospital pharmacies and drug stores.
Product Definition:
Acetazolamide is a carbonic anhydrase inhibitor used to treat glaucoma, epilepsy, and altitude sickness. It decreases the production of fluid in the eye, which helps to lower pressure inside the eye.
Tablets:
Tablets are small pieces of material made up of different substances such as cellulose, calcium carbonate, and aluminum. They can be used to treat a variety of ailments such as arthritis, asthma, and other respiratory disorders. Tablets are easy to swallow owing to their soft texture which makes them easily consumable in nature.
Capsule:
Capsule is a small package that contains medicine and it protects the medicines from getting into contact with light, air, moisture and UV rays. The size of capsule depends upon the type of drug. Capsules are mostly used for tablets or capsules containing drugs. Some capsules also contain liquid drugs inside them so that they can be consumed easily by mouth without affecting the taste.
Acetazolamide is used to treat glaucoma.
Application Insights:
The drug store segment held the largest share of more than 70.0% in 2017. The increasing usage of acetazolamide for treating glaucoma, acute mountain sickness, and altitude sickness is expected to drive the demand for a market that is primarily driven by retail pharmacies dispensing medicines at the site nearest to customers¢â‚¬â„¢ homes.
Acetazolamide injection is used as an anticonvulsant and sedative agent in epilepsy treatment; it also finds applications as an inhalation anaesthetic during surgical procedures involving nasal catheters or endoscopy. It has been approved by U.
Regional Analysis:
North America dominated the global market in 2017 owing to the presence of a large number of manufacturers and distributors. The region is expected to maintain its dominance over the forecast period due to increasing awareness about drug usage, rising healthcare spending, and growing use in treating glaucoma. In addition, increasing prevalence of diabetes is also anticipated to fuel demand for this drug in North America during the forecast period.
Asia Pacific accounted for a revenue share of 15% in 2017 owing to high unmet clinical needs coupled with rapidly improving healthcare infrastructure & expenditure levels especially in emerging countries such as China & India are expected favorably impact growth prospects over coming years.
In Europe, this medication is used primarily as an eye drop or injection into muscle tissue around each eye (bilateral).
Growth Factors:
- Increasing prevalence of altitude sickness: Acetazolamide is the most commonly prescribed drug for the prevention and treatment of altitude sickness. The increasing prevalence of altitude sickness is expected to drive the growth of acetazolamide market.
- Growing awareness about acetazolamide: There is a growing awareness among people about acetazolamide and its benefits in preventing and treating altitude sickness, glaucoma, epilepsy, etc. This is expected to boost the demand for acetazolamide in coming years.
- Rising number of mountain climbers: The number of mountain climbers is increasing rapidly across the globe due to advent of new adventure sports such as rock climbing, ice climbing, etc. This is likely to create a positive impact on the growth prospects of acetazolamide market in coming years.
Scope Of The Report
Report Attributes
Report Details
Report Title
Acetazolamide Market Research Report
By Type
Tablets, Capsule, Injection
By Application
Hospital, Drug Store
By Companies
Teva, TARO, Zydus Pharmaceuticals, Lannett Company, Sun Pharmaceutical, Heritage Pharmaceuticals, Nostrum Laboratories, Accord Healthcare, Strides Pharma, West-Ward Pharmaceuticals, X-Gen Pharmaceuticals, Mylan, Emcure
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
176
Number of Tables & Figures
124
Customization Available
Yes, the report can be customized as per your need.
Global Acetazolamide Market Report Segments:
The global Acetazolamide market is segmented on the basis of:
Types
Tablets, Capsule, Injection
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Drug Store
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Teva
- TARO
- Zydus Pharmaceuticals
- Lannett Company
- Sun Pharmaceutical
- Heritage Pharmaceuticals
- Nostrum Laboratories
- Accord Healthcare
- Strides Pharma
- West-Ward Pharmaceuticals
- X-Gen Pharmaceuticals
- Mylan
- Emcure
Highlights of The Acetazolamide Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Tablets
- Capsule
- Injection
- By Application:
- Hospital
- Drug Store
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Acetazolamide Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Acetazolamide is a medication used to treat glaucoma and other eye conditions. It works by decreasing the amount of fluid in the eyes.
Some of the major companies in the acetazolamide market are Teva, TARO, Zydus Pharmaceuticals, Lannett Company, Sun Pharmaceutical, Heritage Pharmaceuticals, Nostrum Laboratories, Accord Healthcare, Strides Pharma, West-Ward Pharmaceuticals, X-Gen Pharmaceuticals, Mylan, Emcure.
The acetazolamide market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Acetazolamide Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Acetazolamide Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Acetazolamide Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Acetazolamide Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Acetazolamide Market Size & Forecast, 2018-2028
4.5.1 Acetazolamide Market Size and Y-o-Y Growth
4.5.2 Acetazolamide Market Absolute $ Opportunity
Chapter 5 Global Acetazolamide Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Acetazolamide Market Size Forecast by Type
5.2.1 Tablets
5.2.2 Capsule
5.2.3 Injection
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Acetazolamide Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Acetazolamide Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Drug Store
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Acetazolamide Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Acetazolamide Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Acetazolamide Analysis and Forecast
9.1 Introduction
9.2 North America Acetazolamide Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Acetazolamide Market Size Forecast by Type
9.6.1 Tablets
9.6.2 Capsule
9.6.3 Injection
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Acetazolamide Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Drug Store
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Acetazolamide Analysis and Forecast
10.1 Introduction
10.2 Europe Acetazolamide Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Acetazolamide Market Size Forecast by Type
10.6.1 Tablets
10.6.2 Capsule
10.6.3 Injection
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Acetazolamide Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Drug Store
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Acetazolamide Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Acetazolamide Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Acetazolamide Market Size Forecast by Type
11.6.1 Tablets
11.6.2 Capsule
11.6.3 Injection
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Acetazolamide Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Drug Store
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Acetazolamide Analysis and Forecast
12.1 Introduction
12.2 Latin America Acetazolamide Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Acetazolamide Market Size Forecast by Type
12.6.1 Tablets
12.6.2 Capsule
12.6.3 Injection
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Acetazolamide Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Drug Store
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Acetazolamide Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Acetazolamide Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Acetazolamide Market Size Forecast by Type
13.6.1 Tablets
13.6.2 Capsule
13.6.3 Injection
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Acetazolamide Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Drug Store
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Acetazolamide Market: Competitive Dashboard
14.2 Global Acetazolamide Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Teva
14.3.2 TARO
14.3.3 Zydus Pharmaceuticals
14.3.4 Lannett Company
14.3.5 Sun Pharmaceutical
14.3.6 Heritage Pharmaceuticals
14.3.7 Nostrum Laboratories
14.3.8 Accord Healthcare
14.3.9 Strides Pharma
14.3.10 West-Ward Pharmaceuticals
14.3.11 X-Gen Pharmaceuticals
14.3.12 Mylan
14.3.13 Emcure
